Related references
Note: Only part of the references are listed.The clinicopathological relevance of uniform CD56 expression in anaplastic large cell lymphoma: a retrospective analysis of 18 cases
Bao-Hua Yu et al.
DIAGNOSTIC PATHOLOGY (2021)
STAT3 and TP53 mutations associate with poor prognosis in anaplastic large cell lymphoma
Cosimo Lobello et al.
LEUKEMIA (2021)
How I Diagnose Anaplastic Large Cell Lymphoma
Catalina Amador et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2021)
Next generation sequencing of breast implant-associated anaplastic large cell lymphomas reveals a novel STAT3-JAK2 fusion among other activating genetic alterations within the JAK-STAT pathway
Andres E. Quesada et al.
BREAST JOURNAL (2021)
Is immunohistochemical expression of GATA3 helpful in the differential diagnosis of transformed mycosis fungoides and primary cutaneous CD30-positive T cell lymphoproliferative disorders?
Katrina Collins et al.
VIRCHOWS ARCHIV (2021)
Primary cutaneous anaplastic large-cell lymphoma: a review of the SEER database from 2005 to 2016
H. Sarfraz et al.
CLINICAL AND EXPERIMENTAL DERMATOLOGY (2021)
Primary cutaneous anaplastic large-cell lymphoma with 6p25.3 rearrangement exhibits a biphasic histopathologic pattern: Two case reports and literature review
Yan-ning Xue et al.
JOURNAL OF CUTANEOUS PATHOLOGY (2021)
Epstein-Barr-virus-positive large B-cell lymphoma associated with breast implants: an analysis of eight patients suggesting a possible pathogenetic relationship
L. Jeffrey Medeiros et al.
MODERN PATHOLOGY (2021)
Leukaemic relapse of anaplastic large cell lymphoma, ALK negative
Nabin Raj Karki et al.
BMJ CASE REPORTS (2021)
ALK-negative primary cutaneous T-cell anaplastic large cell lymphoma, myxoid variant; masquerading as sarcoma: unveiling the diagnostic dilemma
Medha Misra et al.
BMJ CASE REPORTS (2021)
Striking Association of Lymphoid Enhancing Factor (LEF1) Overexpression and DUSP22 Rearrangements in Anaplastic Large Cell Lymphoma
Aishwarya Ravindran et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2021)
Recurrent Primary Cutaneous Anaplastic Large Cell Lymphoma With Systemic Involvement: A Case Report and Literature Review
Elizabeth Philippe et al.
CUREUS JOURNAL OF MEDICAL SCIENCE (2021)
A proposal for pathologic processing of breast implant capsules in patients with suspected breast implant anaplastic large cell lymphoma
Kirill A. Lyapichev et al.
MODERN PATHOLOGY (2020)
Gene alterations in epigenetic modifiers and JAK-STAT signaling are frequent in breast implant-associated ALCL
Camille Laurent et al.
BLOOD (2020)
ALCL by any other name: the many facets of anaplastic large cell lymphoma
Lina Irshaid et al.
PATHOLOGY (2020)
What is the Evidence of Lymphoma in Patients with Prostheses Other Than Breast Implants?
Guillermo Ramos-Gallardo et al.
AESTHETIC PLASTIC SURGERY (2020)
EBV+ diffuse large B-cell lymphoma associated with chronic inflammation expands the spectrum of breast implant-related lymphomas
Lenaig Mescam et al.
BLOOD (2020)
Breast implant-associated anaplastic large cell lymphoma: A comprehensive review
Antonio Marra et al.
CANCER TREATMENT REVIEWS (2020)
Best Practices Guideline for the Pathologic Diagnosis of Breast Implant-Associated Anaplastic Large-Cell Lymphoma
Elaine S. Jaffe et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Increased prevalence of BRCA1/2 mutations in women with macrotextured breast implants and anaplastic large cell lymphoma of the breast
Mintsje de Boer et al.
BLOOD (2020)
Breast Implant-associated Anaplastic Large Cell Lymphoma: Review and Multiparametric Imaging Paradigms
Bhupinder Sharma et al.
RADIOGRAPHICS (2020)
Primary Cutaneous CD30+Lymphoproliferative Disorders: a Comprehensive Review
Cosimo Di Raimondo et al.
CURRENT HEMATOLOGIC MALIGNANCY REPORTS (2020)
What is the Process for Breast Implant Manufacturing? Inside Eight Breast Implant Factories
Guillermo Ramos-Gallardo et al.
AESTHETIC PLASTIC SURGERY (2020)
B-cell lymphomas associated with breast implants: Report of three cases and review of the literature
Mark G. Evans et al.
ANNALS OF DIAGNOSTIC PATHOLOGY (2020)
Breast Implant-associated Anaplastic Large Cell Lymphoma Incidence Determining an Accurate Risk
Jonas A. Nelson et al.
ANNALS OF SURGERY (2020)
Chromosome 20 loss is characteristic of breast implant-associated anaplastic large cell lymphoma
G. Tjitske Los-de Vries et al.
BLOOD (2020)
American Registry of Pathology Expert Opinions: Recommendations for the diagnostic workup of mature T cell neoplasms
Francisco Vega et al.
ANNALS OF DIAGNOSTIC PATHOLOGY (2020)
ALK-negative CNS anaplastic large cell lymphoma: case report and review of literature
Melissa Lannon et al.
BRITISH JOURNAL OF NEUROSURGERY (2020)
Etiology of Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL): Current Directions in Research
Anand K. Deva et al.
CANCERS (2020)
Leukemic phase of ALK-negative anaplastic large cell lymphoma in a patient who is on androgenic steroids: A case report
Ganesh Kasinathan
ANNALS OF MEDICINE AND SURGERY (2020)
Silicone granuloma mimicking Breast Implant Associated Large Cell Lymphoma (BIA-ALCL): a case report
Elizabeth Shepard et al.
CASE REPORTS IN PLASTIC SURGERY AND HAND SURGERY (2020)
Breast implant-associated anaplastic large cell lymphoma: a review
Andres E. Quesada et al.
MODERN PATHOLOGY (2019)
2019 NCCN Consensus Guidelines on the Diagnosis and Treatment of Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL)
Mark W. Clemens et al.
AESTHETIC SURGERY JOURNAL (2019)
Recurrent MSCE116K mutations in ALK-negative anaplastic large cell lymphoma
Rebecca A. Luchtel et al.
BLOOD (2019)
p53 and β-Catenin Expression Predict Poorer Prognosis in Patients With Anaplastic Large-Cell Lymphoma
Aida Ibricevic Richardson et al.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (2019)
Dual-Specificity Phosphatases in Immunity and Infection: An Update
Roland Lang et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Variable loss of CD30 expression by immunohistochemistry in recurrent cutaneous CD30+lymphoid neoplasms treated with brentuximab vedotin
Amrita Goyal et al.
JOURNAL OF CUTANEOUS PATHOLOGY (2019)
Expression of P63 and its correlation with prognosis in diffuse large B-cell lymphoma: a single center experience
Wan-Ming Hu et al.
DIAGNOSTIC PATHOLOGY (2019)
A practical cytological approach to the diagnosis of breast-implant associated anaplastic large cell lymphoma
Ellis Barbe et al.
CYTOPATHOLOGY (2019)
DUSP22-rearranged anaplastic lymphomas are characterized by specific morphological features and a lack of cytotoxic and JAK/STAT surrogate markers
Arantza Onaindia et al.
HAEMATOLOGICA (2019)
CD30-positive primary cutaneous lymphoproliferative disorders: molecular alterations and targeted therapies
Lucia Prieto-Torres et al.
HAEMATOLOGICA (2019)
Comparative pathologic analysis of mediastinal B-cell lymphomas: selective expression of p63 but no GATA3 optimally differentiates primary mediastinal large B-cell lymphoma from classic Hodgkin lymphoma
Hyun-Jung Kim et al.
DIAGNOSTIC PATHOLOGY (2019)
CD30+ T-cell lymphoproliferative disorders
James M. Martin et al.
CHINESE CLINICAL ONCOLOGY (2019)
Targeted next generation sequencing of breast implant-associated anaplastic large cell lymphoma reveals mutations in JAK/STAT signalling pathway genes, TP53 and DNMT3A
Arianna Di Napoli et al.
BRITISH JOURNAL OF HAEMATOLOGY (2018)
Expression analyses of Dusp22 (Dual-specificity phosphatase 22) in mouse tissues
Nanako Hamada et al.
MEDICAL MOLECULAR MORPHOLOGY (2018)
Clinicopathologic Features and Prognostic Impact of Lymph Node Involvement in Patients With Breast Implant-associated Anaplastic Large Cell Lymphoma
Maria C. Ferrufino-Schmidt et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2018)
Genetic subtyping of breast implant-associated anaplastic large cell lymphoma
Naoki Oishi et al.
BLOOD (2018)
IL-13 is produced by tumor cells in breast implant-associated anaplastic large cell lymphoma: implications for pathogenesis
Marshall E. Kadin et al.
HUMAN PATHOLOGY (2018)
Breast Implants and the Risk of Anaplastic Large-Cell Lymphoma in the Breast
Mintsje de Boer et al.
JAMA ONCOLOGY (2018)
Molecular profiling reveals immunogenic cues in anaplastic large cell lymphomas with DUSP22 rearrangements
Rebecca A. Luchtel et al.
BLOOD (2018)
Prognostic and therapeutic significance of phosphorylated STAT3 and protein tyrosine phosphatase-6 in peripheral-T cell lymphoma
Jing Jing Han et al.
BLOOD CANCER JOURNAL (2018)
Frequent activating STAT3 mutations and novel recurrent genomic abnormalities detected in breast implant-associated anaplastic large cell lymphoma
Piers Blombery et al.
Oncotarget (2018)
Expression of p63 protein in anaplastic large cell lymphoma: implications for genetic subtyping
Xueju Wang et al.
HUMAN PATHOLOGY (2017)
ALK-positive primary cutaneous anaplastic large cell lymphoma: a case report and review of the literature
Shamir Geller et al.
INTERNATIONAL JOURNAL OF DERMATOLOGY (2017)
Primary cutaneous anaplastic large cell lymphoma
Ryanne A. Brown et al.
JOURNAL OF CUTANEOUS PATHOLOGY (2017)
Functional biocompatibility testing of silicone breast implants and a novel classification system based on surface roughness
S. Barr et al.
JOURNAL OF THE MECHANICAL BEHAVIOR OF BIOMEDICAL MATERIALS (2017)
Breast Implant-Associated Anaplastic Large Cell Lymphoma in Australia and New Zealand: High-Surface-Area Textured Implants Are Associated with Increased Risk
Anna Loch-Wilkinson et al.
PLASTIC AND RECONSTRUCTIVE SURGERY (2017)
Cytological diagnostic features of late breast implant seromas: From reactive to anaplastic large cell lymphoma
Arianna Di Napoli et al.
PLOS ONE (2017)
A new era for cutaneous CD30-positive T-cell lymphoproliferative disorders
Werner Kempf
SEMINARS IN DIAGNOSTIC PATHOLOGY (2017)
CD30+T Cells in Late Seroma May Not Be Diagnostic of Breast Implant-Associated Anaplastic Large Cell Lymphoma
Marshall E. Kadin et al.
AESTHETIC SURGERY JOURNAL (2017)
Breast Implant-Associated Anaplastic Large-Cell Lymphoma in a Transgender Woman
Mintsje de Boer et al.
AESTHETIC SURGERY JOURNAL (2017)
Understanding CD30 biology and therapeutic targeting: a historical perspective providing insight into future directions
C. A. van der Weyden et al.
BLOOD CANCER JOURNAL (2017)
JNK Pathway-Associated Phosphatase/DUSP22 Suppresses CD4+ T-Cell Activation and Th1/Th17-Cell Differentiation and Negatively Correlates with Clinical Activity in Inflammatory Bowel Disease
Rui Zhou et al.
FRONTIERS IN IMMUNOLOGY (2017)
Primary Cutaneous Small Cell Variant of Anaplastic Large Cell Lymphoma: A Case Series and Review of the Literature
Cynthia M. Magro et al.
AMERICAN JOURNAL OF DERMATOPATHOLOGY (2017)
Anaplastic large cell lymphoma: pathology, genetics, and clinical aspects
Naoko Tsuyama et al.
JOURNAL OF CLINICAL AND EXPERIMENTAL HEMATOPATHOLOGY (2017)
Anaplastic large cell lymphoma: clinicopathological and immunohistochemical study of 20 cases classified according to the 2016 revision of the World Health Organization classification of lymphoid neoplasms
Diana Brisa Sevilla-Lizcano et al.
GACETA MEXICANA DE ONCOLOGIA (2017)
ALK-Negative Anaplastic Large Cell Lymphoma with Urinary Bladder Involvement Diagnosed in Urine Cytology: A Case Report and Literature Review
Joao Lobo et al.
DIAGNOSTIC CYTOPATHOLOGY (2017)
Breast implant-associated anaplastic large cell lymphoma: two distinct clinicopathological variants with different outcomes
C. Laurent et al.
ANNALS OF ONCOLOGY (2016)
Identification of a new subclass of ALK-negative ALCL expressing aberrant levels of ERBB4 transcripts
Irene Scarfo et al.
BLOOD (2016)
Immunocytochemical p63 expression discriminates between primary cutaneous follicle centre cell and diffuse large B cell lymphoma-leg type, and is of the TAp63 isoform
Alistair Robson et al.
HISTOPATHOLOGY (2016)
Classical Hodgkin Lymphoma Arising Adjacent to a Breast Implant
Ciara Ryan et al.
INTERNATIONAL JOURNAL OF SURGICAL PATHOLOGY (2016)
Complete Surgical Excision Is Essential for the Management of Patients With Breast Implant-Associated Anaplastic Large-Cell Lymphoma
Mark W. Clemens et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Loss of CD30 expression after treatment with brentuximab vedotin in a patient with anaplastic large cell lymphoma: a novel finding
Rami N. Al-Rohil et al.
JOURNAL OF CUTANEOUS PATHOLOGY (2016)
Skin involvement as the first manifestation of breast implant-associated anaplastic large cell lymphoma
Rebeca Alcala et al.
JOURNAL OF CUTANEOUS PATHOLOGY (2016)
Development of a primary cutaneous CD30(+) anaplastic large-cell T-cell lymphoma during treatment of multiple sclerosis with fingolimod
Despoina Papathemeli et al.
MULTIPLE SCLEROSIS JOURNAL (2016)
Bacterial Biofilm Infection Detected in Breast Implant-Associated Anaplastic Large-Cell Lymphoma
Honghua Hu et al.
PLASTIC AND RECONSTRUCTIVE SURGERY (2016)
Downregulation of the phosphatase JKAP/DUSP22 in T cells as a potential new biomarker of systemic lupus erythematosus nephritis
Huai-Chia Chuang et al.
ONCOTARGET (2016)
Molecular alterations and tumor suppressive function of the DUSP22 (Dual Specificity Phosphatase 22) gene in peripheral T-cell lymphoma subtypes
Pierre Melard et al.
ONCOTARGET (2016)
Insights into the Pathogenesis of Anaplastic Large-Cell Lymphoma through Genome-wide DNA Methylation Profiling
Melanie R. Hassler et al.
CELL REPORTS (2016)
Development of a primary cutaneous CD30(+) anaplastic large-cell T-cell lymphoma during treatment of multiple sclerosis with fingolimod
Despoina Papathemeli et al.
MULTIPLE SCLEROSIS JOURNAL (2016)
Anaplastic Large Cell Lymphomas: ALK Positive, ALK Negative, and Primary Cutaneous
Xiaoming Xing et al.
ADVANCES IN ANATOMIC PATHOLOGY (2015)
Congenital Primary Cutaneous Anaplastic Large-Cell Lymphoma: A Case Report
An Na Seo et al.
AMERICAN JOURNAL OF DERMATOPATHOLOGY (2015)
Intralymphatic Spread Is a Common Finding in Cutaneous CD30+ Lymphoproliferative Disorders
Gerardo Ferrara et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2015)
Convergent Mutations and Kinase Fusions Lead to Oncogenic STAT3 Activation in Anaplastic Large Cell Lymphoma
Ramona Crescenzo et al.
CANCER CELL (2015)
Galectin-3 Expression in Primary Cutaneous CD30-Positive Lymphoproliferative Disorders and Transformed Mycosis Fungoides
Christina Mitteldorf et al.
DERMATOLOGY (2015)
Silicone implants and lymphoma: The role of inflammation
Mojca Bizjak et al.
JOURNAL OF AUTOIMMUNITY (2015)
ALK-positive (2p23 rearranged) anaplastic large cell lymphoma with localization to the skin in a pediatric patient
Melissa Pulitzer et al.
JOURNAL OF CUTANEOUS PATHOLOGY (2015)
CD30+ cutaneous lymphoproliferative disorders with pseudocarcinomatous hyperplasia are associated with a T-helper-17 cytokine profile and infiltrating granulocytes
Joan Guitart et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2015)
Anaplastic Large Cell Lymphoma Occurring in Women with Breast Implants: Analysis of 173 Cases
Garry S. Brody et al.
PLASTIC AND RECONSTRUCTIVE SURGERY (2015)
Morphologic Features of ALK-negative Anaplastic Large Cell Lymphomas With DUSP22 Rearrangements
Rebecca L. King et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2015)
Essential role of IRF4 and MYC signaling for survival of anaplastic large cell lymphoma
Andre Weilemann et al.
BLOOD (2015)
Anaplastic Large Cell Lymphoma Features Presenting Diagnostic Challenges
Maria A. Pletneva et al.
ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE (2014)
ALK-negative anaplastic large cell lymphoma is a genetically heterogeneous disease with widely disparate clinical outcomes
Edgardo R. Parrilla Castellar et al.
BLOOD (2014)
Breast implant-associated anaplastic large cell lymphoma: sensitivity, specificity, and findings of imaging studies in 44 patients
Beatriz E. Adrada et al.
BREAST CANCER RESEARCH AND TREATMENT (2014)
Breast Implant-Associated Anaplastic Large-Cell Lymphoma: Long-Term Follow-Up of 60 Patients
Roberto N. Miranda et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
A novel immunohistochemical classifier to distinguish Hodgkin lymphoma from ALK anaplastic large cell lymphoma
Claudia Doering et al.
MODERN PATHOLOGY (2014)
The phosphatase JKAP/DUSP22 inhibits T-cell receptor signalling and autoimmunity by inactivating Lck
Ju-Pi Li et al.
NATURE COMMUNICATIONS (2014)
Intravascular ALK-negative Anaplastic Large Cell Lymphoma With Localized Cutaneous Involvement and an Indolent Clinical Course Toward Recognition of a Distinct Clinicopathologic Entity
Ryan A. Metcalf et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2013)
Chromosomal Rearrangements of 6p25.3 Define a New Subtype of Lymphomatoid Papulosis
Laszlo J. Karai et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2013)
Anaplastic large cell lymphoma, ALK-negative
Andres J. M. Ferreri et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2013)
Primary Cutaneous Anaplastic Large Cell Lymphoma with Angioinvasive Features and Cytotoxic Phenotype: A Rare Lymphoma Variant within the Spectrum of CD30+ Lymphoproliferative Disorders
Werner Kempf et al.
DERMATOLOGY (2013)
Silicone implant incompatibility syndrome (SIIS): A frequent cause of ASIA (Shoenfeld's syndrome)
J. W. Cohen Tervaert et al.
IMMUNOLOGIC RESEARCH (2013)
Mediatory role of interleukin-6 in α smooth muscle actin induction and myofibroblast formation around silicone tissue expander
Josna Joseph et al.
JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A (2013)
Anaplastic Large-Cell Lymphoma With Aberrant Expression of Multiple Cytokeratins Masquerading As Metastatic Carcinoma of Unknown Primary
TuDung T. Nguyen et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Two cases of CD30+, anaplastic lymphoma kinase (ALK)-negative anaplastic large cell lymphoma with oral manifestations
Anupama Grandhi et al.
ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY (2013)
Identification of a 3-gene model as a powerful diagnostic tool for the recognition of ALK-negative anaplastic large-cell lymphoma
Luca Agnelli et al.
BLOOD (2012)
ALK-positive anaplastic large cell lymphoma limited to the skin: clinical, histopathological and molecular analysis of 6 pediatric cases. A report from the ALCL99 study
I. Oschlies et al.
HAEMATOLOGICA (2012)
T Regulatory Cells and TH17 Cells in Peri-Silicone Implant Capsular Fibrosis
Dolores Wolfram et al.
PLASTIC AND RECONSTRUCTIVE SURGERY (2012)
Primary cutaneous CD30 positive T-cell lymphoproliferative disorders with aberrant expression of PAX5: Report of three cases
Masahiro Hagiwara et al.
PATHOLOGY INTERNATIONAL (2012)
Epithelioid Inflammatory Myofibroblastic Sarcoma: An Aggressive Intra-abdominal Variant of Inflammatory Myofibroblastic Tumor With Nuclear Membrane or Perinuclear ALK
Adrian Marino-Enriquez et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2011)
Discovery of recurrent t(6;7)(p25.3;q32.3) translocations in ALK-negative anaplastic large cell lymphomas by massively parallel genomic sequencing
Andrew L. Feldman et al.
BLOOD (2011)
Breast Implant-Associated, ALK-Negative, T-Cell, Anaplastic, Large-Cell Lymphoma: Establishment and Characterization of a Model Cell Line (TLBR-1) for This Newly Emerging Clinical Entity
Melissa G. Lechner et al.
CANCER (2011)
p63 is a suppressor of tumorigenesis and metastasis interacting with mutant p53
G. Melino
CELL DEATH AND DIFFERENTIATION (2011)
Pathobiology of ALK-negative anaplastic large cell lymphoma
Stefano A. Pileri et al.
PEDIATRIC REPORTS (2011)
Of Lymphocytes and Cutaneous Epithelium: Keratoacanthomatous Hyperplasia in CD30+Lymphoproliferative Disorders and CD30+Cells Associated With Keratoacanthoma
Kenneth S. Resnik et al.
AMERICAN JOURNAL OF DERMATOPATHOLOGY (2010)
PAX5-positive T-cell anaplastic large cell lymphomas associated with extra copies of the PAX5 gene locus
Andrew L. Feldman et al.
MODERN PATHOLOGY (2010)
ALK-negative anaplastic large cell lymphoma in leukemic phase with near-pentaploidy
W. S. Wong et al.
LEUKEMIA & LYMPHOMA (2010)
ALK-negative anaplastic large cell lymphoma with extensive peripheral blood and bone marrow involvements manifested as leukemic phase
Ying Lu et al.
LEUKEMIA RESEARCH (2010)
Spectrum of CD30+ Lymphoid Proliferations in the Eyelid Lymphomatoid Papulosis, Cutaneous Anaplastic Large Cell Lymphoma, and Anaplastic Large Cell Lymphoma
R. Krishna Sanka et al.
OPHTHALMOLOGY (2010)
Dual-specificity phosphatases: critical regulators with diverse cellular targets
Kate I. Patterson et al.
BIOCHEMICAL JOURNAL (2009)
Neutrophil/eosinophil-rich type of primary cutaneous anaplastic large cell lymphoma: a clinicopathological, immunophenotypic and molecular study of nine cases
Yun-Yi Kong et al.
HISTOPATHOLOGY (2009)
p63 Protein expression in high risk diffuse large B-cell lymphoma
A. E. Hallack Neto et al.
JOURNAL OF CLINICAL PATHOLOGY (2009)
Clusterin expression in cutaneous CD30-positive lymphoproliferative disorders and their histologic simulants
Stephen H. Olsen et al.
JOURNAL OF CUTANEOUS PATHOLOGY (2009)
Primary Testicular Presentation of ALK-1-negative Anaplastic Large Cell Lymphoma in a Pediatric Patient
Joanne Lagmay et al.
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY (2009)
Primary ALK-1-negative anaplastic large cell lymphoma of the brain: Case report and review of the literature
Kunihiko Kodama et al.
NEUROPATHOLOGY (2009)
The expression of myeloid antigens CD13 and/or CD33 is a marker of ALK plus anaplastic large cell lymphomas
Ian M. Bovio et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2008)
Lymphomas involving the breast - A study of 106 cases comparing localized and disseminated neoplasms
Sameer S. Talwalkar et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2008)
ALK-anaplastic large-cell lymphoma is clinically and immunophenotypically different from both ALK+ ALCL and peripheral T-cell lymphoma, not otherwise specified:: report from the International Peripheral T-Cell Lymphoma Project
Kerry J. Savage et al.
BLOOD (2008)
Genomic profiling reveals different genetic aberrations in systemic ALK-positive and ALK-negative anaplastic large cell lymphomas
Itziar Salaverria et al.
BRITISH JOURNAL OF HAEMATOLOGY (2008)
Cutaneous lymphocyte antigen expression in benign and neoplastic cutaneous B- and T-cell lymphoid infiltrates
Cynthia M. Magro et al.
JOURNAL OF CUTANEOUS PATHOLOGY (2008)
Seroma-associated primary anaplastic large-cell lymphoma adjacent to breast implants: an indolent T-cell lymphoproliferative disorder
Anja C. Roden et al.
MODERN PATHOLOGY (2008)
Gene-expression profiling of systemic anaplastic large-cell lymphoma reveals differences based on ALK status and two distinct morphologic ALK+ subtypes
Laurence Lamant et al.
BLOOD (2007)
TAp63 and ΔNp63 in cancer and epidermal development
Eleonora Candi et al.
CELL CYCLE (2007)
The JAK-STAT signaling pathway: Input and output intergration
Peter J. Murray
JOURNAL OF IMMUNOLOGY (2007)
Epstein-Barr virus in CD30+ anaplastic large cell lymphoma involving the skin and lymphomatoid papulosis in South Korea
You Chan Kim et al.
INTERNATIONAL JOURNAL OF DERMATOLOGY (2006)
Clinico-pathological characteristics of p63 expression in B-cell lymphoma
Noriyasu Fukushima et al.
CANCER SCIENCE (2006)
Regulation of STAT3-mediated signaling by LMW-DSP2
Y. Sekine et al.
ONCOGENE (2006)
Rare expression of T-cell markers in classical Hodgkin's lymphoma
A Tzankov et al.
MODERN PATHOLOGY (2005)
Expression of TP73L is a helpful diagnostic marker of primary mediastinal large B-cell lymphomas
A Zamò et al.
MODERN PATHOLOGY (2005)
Expression of p63 in diffuse large B-cell lymphoma
CV Hedvat et al.
APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY (2005)
Primary cutaneous CD30-positive anaplastic large cell lymphoma in childhood: Report of 4 cases and review of the literature
S Kumar et al.
PEDIATRIC AND DEVELOPMENTAL PATHOLOGY (2005)
Anaplastic large cell lymphoma presenting as a pleural effusion and mimicking primary effusion lymphoma - A report of 2 cases
ACL Chan et al.
ACTA CYTOLOGICA (2003)
Genetic alterations in primary cutaneous CD30+anaplastic large cell lymphoma
X Mao et al.
GENES CHROMOSOMES & CANCER (2003)
Pyogenic lymphoma of the skin: a peculiar variant of primary cutaneous neutrophil-rich CD30+anaplastic large-cell lymphoma. Clinicopathological study of four cases and review of the literature
G Burg et al.
BRITISH JOURNAL OF DERMATOLOGY (2003)
The dual specificity JKAP specifically activates the c-Jun N-terminal kinase pathway
AJ Chen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Histological and immunohistochemical characterization of extranodal diffuse large-cell lymphomas with prominent spindle cell features
J Wang et al.
HISTOPATHOLOGY (2001)
Anaplastic large cell lymphoma: The shifting sands of diagnostic hematopathology
ES Jaffe
MODERN PATHOLOGY (2001)
Share Paper
